Councils - Pulmonary Transplantation
LINKS NEWSLETTER LIAISON:
Scientific Council on Pulmonary Transplantation
COUNCIL LEADERSHIP OPERATING BOARDCOUNCIL CHAIR: NOT A COUNCIL MEMBER?
Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website
where you can update your membership profile and join any of the 12 Scientific Councils.
in Grand Hall C of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions
The resources below were developed by the ISHLT Pulmonary Transplantation Council QOL Workforce for clinicians and investigators alike. These resources aim to provide organized, up-to-date summaries of information focused on HRQL in lung transplantation.
This annotated bibliography of peer-reviewed publications focused on HRQL in lung transplantation is organized by theme including:
I. Determinants of HRQL
II. Psychosocial factors in HRQL
III. Comparisons of HRQL before and after lung transplantation
IV. Long-term longitudinal studies of HRQL in lung transplant recipients
V. The effect of therapies and interventions on HRQL
VI. Instrument validation and methodology
VII. HRQL as a predictor of clinical outcomes
VIII. Reviews and Editorials
This table is an organized list of the HRQL, health status and utility instruments used in studies examining HRQL in lung transplantation. In addition, links to the original manuscript that introduced each instrument and to the instrument webpage (if available) are provided.
If you are aware of new articles or resources that are missing, please email email@example.com
- 02-01-2017 Operating Board Conference Call Minutes (PDF)
- Lung Transplantation Core Competency Curriculum (ISHLT LTx CCC) PDF
- DCD Guidelines PDF
Orlando, FL, USA
412-770-7636Cynthia.Gries.MD@flhosp.orgDr. Cynthia Gries is the Medical Director of the Lung Transplant Program at Florida Hospital in Orlando, Florida. Dr. Gries attended medical school at the University of Chicago in Chicago, IL. She completed her internal medicine residency at Johns Hopkins University in Baltimore, MD and completed her fellowship at the University of Washington in Seattle, WA. She subsequently completed her masters in Epidemiology at the University of Washington. Dr. Gries is involved in research with her main focus being on improving the long-term outcomes in lung transplant patients. She is an international speaker regarding recipient selection and the lung allocation process. COUNCIL VICE CHAIR:
Washington University School of Medicine
Barnes Jewish Hospital
St. Louis, MO, USArhachem@dom.wustl.eduDr. Hachem completed training in Internal Medicine at the University of Texas Southwestern Medical Center in Dallas then completed training in Pulmonary & Critical Care at Washington University in St. Louis School of Medicine. He is currently the Tracey C. Marshall – Dr. Elbert P. Trulock Distinguished Professor of Medicine at Washington University in St. Louis School of Medicine. He is the Medical Director of the Lung Transplant Program at Washington University and Barnes-Jewish Hospital. His research interests include the role of humoral immunity in allograft rejection and the management of chronic lung allograft dysfunction.COUNCIL PAST CHAIR:
University of Washington School of Medicine
Seattle, Washington, USA
firstname.lastname@example.orgDr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the University of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. He organizes national courses in VATS lobectomy and critical care, and lectures internationally on lung transplantation and lung donor management. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction. Dr. Mulligan attended medical school at the University of Connecticut. He completed his general surgery residency at Columbia Presbyterian in Noew York, NY and took time out during his residency for a two-year post doctoral research fellowship in the laboratory of Dr. Peter Ward at the University of Michigan in Ann Arbor, Michigan. He subsequently completed a heart and lung transplant fellowship at the University of Michigan, followed by a cardiothoracic residency at the University of Michigan and finally a general thoracic fellowship, also at the University of Michigan. During that final year in Ann Arbor, he traveled to San Diego to further study the diagnosis and treatment of Chronic Thromboembolic Hypertension.BOARD OF DIRECTORS LIAISON:
The Prince Charles Hospital
61-7-3350-8111Peter_Hopkins@health.qld.gov.auDr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. executive positions are held with the Australian Lung Foundation (PIVOR and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and national Examiners Panel Royal Australian College of Physicians.EDUCATION WORKFORCE LEADER:
University of California, San Francisco
San Francisco, CA, USA
email@example.comLorriana Leard, MD is an Associate Professor of Clinical Medicine at the University of California San Francisco where she is the Chief of Clinical Operations for the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and the Associate Program Director for the Pulmonary and Critical Care Fellowship Program. Her primary interests are in medical education and lung transplantation. Dr. Leard received her undergraduate degree from Stanford University and her M.D. from the University of California San Diego. After completing her Internal Medicine residency at the University of Texas Southwestern in Dallas, she came to the University of California San Francisco for her Pulmonary and Critical Care Fellowship. She completed an additional subspecialty fellowship in Lung Transplantation at the University of California San Francisco.I2C2 WORKFORCE LEADER:
University of Pennsylvania
Philadephia, PA, USA
firstname.lastname@example.orgBio coming soon...STANDARDS AND GUIDELINES COMMITTEE WORKFORCE LEADER:
The Prince Charles Hospital
61-7-3350-8111Peter_Hopkins@health.qld.gov.auDr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, University of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. executive positions are held with the Australian Lung Foundation (PIVOR and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and national Examiners Panel Royal Australian College of Physicians.QUALITY OF LIFE WORKFORCE LEADER:
UC San Francisco
San Francisco, CA, USA
email@example.comDr. Jonathan Singer is a transplant pulmonologist and Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at the University of California, San Francisco. At UCSF, he is the Associate Medical Director of Lung Transplant Outcomes Research and is a core investigator with the UCSF Respiratory Epidemiology Group. His research focuses broadly on how lung transplantation improves patient-centered outcomes including functioning, disability, health-related quality of life, and survival. An area of particular interest is how frailty and refined assessments of body composition impact patient-centered outcomes in lung transplant candidates and recipients.
Dr. Singer received his undergraduate degree from Stanford University and a Masters in Health and Medical Sciences from the School of Public Health at UC Berkeley. He moved to UCSF to complete his medical degree, residency in internal medicine, and fellowships in pulmonary, critical care, and lung transplantation.
University Health Network
Toronto, ON, CANADAjussi.firstname.lastname@example.orgBio coming soon...LIAISONS TO OTHER COUNCILS:
Stanford, CA, USA
email@example.comDr. Joshua Mooney is a Clinical Assistant Professor at Stanford University who specializes in the care of interstitial lung disease and lung transplant patients. He received his medical degree at University of Minnesota and then completed Internal Medicine residency at the University of California San Francisco followed by Pulmonary and Critical Care Fellowship and a Masters degree in Health Services Research at Stanford University. He performs health services and outcomes research focused on improving the lives and care of patients with advanced lung disease and is actively involved in clinical trials to improve outcomes in interstitial lung disease.